Filtros de búsqueda

Lista de obras de

A Novel Role for Cathepsin S as a Potential Biomarker in Triple Negative Breast Cancer

artículo científico publicado en 2019

Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer

artículo científico publicado en 2021

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

scientific article published on 17 December 2018

BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers ⬇️

artículo científico publicado el 28 de noviembre de 2011

BRCA1 – Conductor of the Breast Stem Cell Orchestra: The Role of BRCA1 in Mammary Gland Development and Identification of Cell of Origin of BRCA1 Mutant Breast Cancer ⬇️

artículo científico publicado el 1 de septiembre de 2012

Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

scientific article published on 20 May 2020

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention

artículo científico publicado en 2015

NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

artículo científico publicado en 2019

PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer

artículo científico publicado en 2019

Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer

scientific article published on 09 March 2020

Quantification of HER2 heterogeneity in breast cancer-implications for identification of sub-dominant clones for personalised treatment

artículo científico publicado en 2016

TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells

scientific article published on 28 June 2019

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda